Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections

Complicated intra-abdominal infections (cIAI) represent a large proportion of all hospital admissions and are a major cause of morbidity and mortality in the intensive care unit. Rising rates of multidrug resistant organisms (MDRO), including extended-spectrum β-lactamase producing Enterobacteriacea...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodlet, Kellie J, Nicolau, David P, Nailor, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140030/
https://www.ncbi.nlm.nih.gov/pubmed/27942218
http://dx.doi.org/10.2147/TCRM.S120811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140030/
https://www.ncbi.nlm.nih.gov/pubmed/27942218
http://dx.doi.org/10.2147/TCRM.S120811

Ejemplares similares